Clinical Trial Update: Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Ethyl-EPA for major depressive disorder has completed; the snippet does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ethyl-EPA (ethyl eicosapentaenoic acid)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Depressive Disorder, Depression | Phase 3 | Status: COMPLETED